EVE Health Group Ltd (EVE)
- 0.018
- +0.002+12.50%
EVE Health Group Ltd (EVE) News
EVE Health Advances Libbo Clinical Program and Hits Apixaban Milestone Amid CEO Transition
EVE Health Advances Libbo Clinical Program and Apixaban Reformulation as New CEO Targets Commercial Growth
EVE Health Group Options Lapse Adjusts Future Equity Dilution
EVE Health Group Trims Potential Dilution as 4 Million Options Lapse
EVE Health Group Director Increases Family's Indirect Shareholding via Off-market Transfer
EVE Health Group Issues 135.4 Million Unquoted Options for Future Capital Flexibility
EVE Health Director Boosts Indirect Stake via Share Placement
EVE Health Group Seeks Quotation for 2.75 Million New Shares
EVE Health Shareholders Back Capital Resolutions at General Meeting
EVE Health Launches Libbo in Australia and Broadens Reformulated Drug Pipeline
EVE Health Group Names Ben Rohr CEO, Refines Leadership to Drive Product Commercialisation
EVE Health Group Calls May 2026 General Meeting, Urges Proxy Voting
EVE Health Group Targets Capital-Light Scale With Reformulated Drug Delivery Platform
EVE Health Seeks ASX Quotation for 64.7 Million New Shares
EVE Health Defines Target Market for Options Tied to Capital Raising
EVE Health Group Launches $1.3m Placement and Options Prospectus
EVE Health Group Lifts Size of Planned Share Placement
EVE Health Group Secures Cornerstone Investor, Lifts Placement to $1.3m
EVE Q4 Earnings Call Highlights
EVE Health Group to Raise Capital via Share Placement and Large Option Issue